Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 Cases. [PDF]
Herrmann A +9 more
europepmc +1 more source
Low-dose ticagrelor combined with aspirin in the prevention of early neurological deterioration of high-risk non-disabling ischemic cerebrovascular events: a PROBE clinical study. [PDF]
Wang M +8 more
europepmc +1 more source
Associations of new intracranial haemorrhage, ischaemic stroke and survival with dual antiplatelet therapy regimen or duration after endovascular treatment for ruptured cerebral aneurysm. [PDF]
Perng PS +8 more
europepmc +1 more source
Dual antiplatelet therapy in acute ischemic stroke: Does diabetes mellitus define a target population? [PDF]
Nedelcu S.
europepmc +1 more source
Single-Site Experience in the ONSET-OFFSET Study Demonstrates Pharmacodynamic and Pharmacokinetic Advantages of Ticagrelor over Clopidogrel in Patients with Chronic Coronary Syndromes. [PDF]
Judge HM, Parker WAE, Storey RF.
europepmc +1 more source
Real-World Antiplatelet Use and Clinical Outcomes in Patients with Advanced Chronic Kidney Disease Following Acute Coronary Syndrome: A Descriptive Cohort Study. [PDF]
Alfehaid L +5 more
europepmc +1 more source
The efficacy and safety of ticagrelor and prasugrel versus clopidogrel in post-PCI dual antiplatelet therapy in chronic coronary syndrome: a systematic review and meta-analysis. [PDF]
Mirhosseini SA +12 more
europepmc +1 more source
Antiplatelet therapy in acute coronary syndrome: a systematic critical appraisal of current guidelines. [PDF]
Xing Y +5 more
europepmc +1 more source
Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. [PDF]
Yang Y +6 more
europepmc +1 more source
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib. [PDF]
Dirir O +4 more
europepmc +1 more source

